Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting, Prophylaxis”

Showing 6 of 0 results

Large-scale testing (Phase 3)Study completedNCT00619359
What this trial is testing

Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 2,322
Large-scale testing (Phase 3)Study completedNCT01499849
What this trial is testing

Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 532
Testing effectiveness (Phase 2)Study completedNCT01031498
What this trial is testing

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

Who this might be right for
Acute Myelogenous LeukemiaChemotherapy-induced Nausea and Vomiting
M.D. Anderson Cancer Center 150
Not applicableUnknownNCT02369107
What this trial is testing

The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Beijing Hospital of Traditional Chinese Medicine 136
Large-scale testing (Phase 3)Study completedNCT05509634
What this trial is testing

Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Who this might be right for
Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Fujian Shengdi Pharmaceutical Co., Ltd. 754
Post-approval studies (Phase 4)Study completedNCT00090207
What this trial is testing

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)

Who this might be right for
NauseaVomiting
Merck Sharp & Dohme LLC 477

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation